# GELSECTAN® and Covert Hepatic Encephalopathy

> **NCT05189834** · NA · WITHDRAWN · sponsor: **Consorci Sanitari de l'Alt Penedès i Garraf**

## Conditions studied

- Covert Hepatic Encephalopathy

## Interventions

- **DIETARY_SUPPLEMENT:** Gelsectan

## Key facts

- **NCT ID:** NCT05189834
- **Lead sponsor:** Consorci Sanitari de l'Alt Penedès i Garraf
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-11
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-07-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The trial was not performed because logistical problems
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05189834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05189834, "GELSECTAN® and Covert Hepatic Encephalopathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05189834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*